Innovent Biologics: Transforming from Regional Leader to Global Premier

Innovent Biologics, Inc. (Innovent) has announced its 2026 interim results and 2030 strategic vision. Dr.

Michael Yu, Founder, Chairman of the Board and CEO of Innovent, highlighted the company’s evolution over the years, emphasizing the transition from a regional leader to a global premier biopharma.…

Source